Peritumoral activated hepatic stellate cells predict poor clinical outcome in hepatocellular carcinoma after curative resection. - Wikidata - wikimedia - TriplyDB

Peritumoral activated hepatic stellate cells predict poor clinical outcome in hepatocellular carcinoma after curative resection.

Peritumoral activated hepatic stellate cells predict poor clinical outcome in hepatocellular carcinoma after curative resection.

http://www.wikidata.org/entity/Q46086837

about

Rationale behind targeting fibroblast activation protein-expressing carcinoma-associated fibroblasts as a novel chemotherapeutic strategy Membrane-to-Nucleus Signals and Epigenetic Mechanisms for Myofibroblastic Activation and Desmoplastic Stroma: Potential Therapeutic Targets for Liver Metastasis?Oral methylthioadenosine administration attenuates fibrosis and chronic liver disease progression in Mdr2-/- mice Causal Modeling of Cancer-Stromal Communication Identifies PAPPA as a Novel Stroma-Secreted Factor Activating NFκB Signaling in Hepatocellular Carcinoma Post-mortem stability of RNA in skeletal muscle and adipose tissue and the tissue-specific expression of myostatin, perilipin and associated factors in the horse.Clinicopathologic and prognostic significance of regulatory T cells in patients with hepatocellular carcinoma: a meta-analysis.Prognostic significance of tumor-associated macrophages in solid tumor: a meta-analysis of the literature.Hepatic stellate cells secretes type I collagen to trigger epithelial mesenchymal transition of hepatoma cells.Combination of intratumoral invariant natural killer T cells and interferon-gamma is associated with prognosis of hepatocellular carcinoma after curative resection.Intratumoral α-SMA enhances the prognostic potency of CD34 associated with maintenance of microvessel integrity in hepatocellular carcinoma and pancreatic cancer.Angiogenin secretion from hepatoma cells activates hepatic stellate cells to amplify a self-sustained cycle promoting liver cancer.Intratumoral hepatic stellate cells as a poor prognostic marker and a new treatment target for hepatocellular carcinoma.High expression of macrophage colony-stimulating factor-1 receptor in peritumoral liver tissue is associated with poor outcome in hepatocellular carcinoma after curative resection Hepatic stellate cell and monocyte interaction contributes to poor prognosis in hepatocellular carcinoma The Histologic Cut-off Point for Adjacent and Remote Non-neoplastic Liver Parenchyma of Hepatocellular Carcinoma in Chronic Hepatitis B Patients.Clinical significance and gene expression study of human hepatic stellate cells in HBV related-hepatocellular carcinoma.Prognostic significance of regulatory T lymphocytes in patients with hepatocellular carcinoma The significant role of mast cells in cancer.Hepatic stellate cells: partners in crime for liver metastases?Role of tumor-associated macrophages in the progression of hepatocellular carcinoma.Encapsulation is a significant prognostic factor for better outcome in large hepatocellular carcinoma.Sorting Out Pandora's Box: Discerning the Dynamic Roles of Liver Microenvironment in Oncolytic Virus Therapy for Hepatocellular Carcinoma.Intratumoral regulatory T cells with higher prevalence and more suppressive activity in hepatocellular carcinoma patients.Cellular prognostic markers in hepatocellular carcinoma.Hepatic stellate cells promote upregulation of epithelial cell adhesion molecule and epithelial-mesenchymal transition in hepatic cancer cells.Activated macrophages down-regulate expression of E-cadherin in hepatocellular carcinoma cells via NF-κB/Slug pathway.Expression and prognostic significance of placental growth factor in hepatocellular carcinoma and peritumoral liver tissue.The inflammatory microenvironment in hepatocellular carcinoma: a pivotal role for tumor-associated macrophages Clinical implications of fibroblast activation protein-α in non-small cell lung cancer after curative resection: a new predictor for prognosis.CCN1/Cyr61 enhances the function of hepatic stellate cells in promoting the progression of hepatocellular carcinoma.Extracellular matrix directs phenotypic heterogeneity of activated fibroblasts.The Role of Cancer-Associated Fibroblasts and Fibrosis in Liver Cancer.Down-regulation of SDF1-α expression in tumor microenvironment is associated with aspirin-mediated suppression of the pro-metastasis effect of sorafenib in hepatocellular carcinoma.Hepatic stellate cells in inflammation-fibrosis-carcinoma axis.Hepatic stellate cells stimulate HCC cell migration via laminin-5 production.Fibroblast activation protein increases metastatic potential of fibrosarcoma line HT1080 through upregulation of integrin-mediated signaling pathways.Interaction of hepatic stellate cells with neutrophils and macrophages in the liver following oncogenic kras activation in transgenic zebrafish.The Expression of FAP in Hepatocellular Carcinoma Cells is Induced by Hypoxia and Correlates with Poor Clinical Outcomes A novel 12-marker panel of cancer-associated fibroblasts involved in progression of hepatocellular carcinoma

P2860

Q27004215-4068B835-7843-452D-A0BB-70362E564BDA Q28084572-A04DE8AF-81E1-4696-A26F-156ED56DFE78 Q28476642-ACBDF5AD-FAFA-4F39-8810-BEBFBC79A8DF Q28547556-8ADFD89B-AEF6-4E29-83AA-83ECD791B4C3 Q33793760-199A1BA3-76AB-4EF2-A978-C8DFE1D3D387 Q33889323-0FAB4ADA-0181-449C-AD38-117AA7F6DAAD Q34531618-BCDE2687-0F93-4AA7-8DA4-F4E9E3F739E0 Q34704882-3AB46796-F88B-4AF9-9EB4-75B3CAD7FC12 Q34934974-95DD7A2D-6B32-436E-A254-5ED3F4F452F8 Q34937019-D7FE1251-F7A8-4E97-843D-29F6C51C5516 Q34990566-0E4134A8-6958-4EF2-8ACC-0C35F289B4C7 Q35053501-60D33E48-B4AC-4761-BAAD-844FF53A3738 Q35584172-F5902F36-5434-4E77-8F15-ADA932BF2AFD Q35889547-0AAD58FA-C8D0-4104-A787-3A544F21E456 Q36343700-24107A25-512E-4FE3-93DE-DB16642AC825 Q36846983-07C9110A-1BD5-456A-9E04-859B41D75A4D Q37520016-E7BA4559-055F-4800-9CB0-940ECE46B610 Q37834484-717701FB-2B1B-4DB7-99E0-01EA08AAF7C9 Q37869041-471F2ACF-03A5-4A65-A749-512B2776AAFE Q37960792-22AC4FBB-17CE-47D8-9898-D06878CB4D5C Q37967593-8FD9BAAD-B2D7-4B57-840A-CE7760373288 Q38209337-E50FEDDD-4AD0-4D72-99F5-8933EF21750F Q38491431-CFD38115-AC33-44A0-ADB1-3A85B8D10C7F Q38515812-48E2367D-2ABD-44A6-B409-45E19F1267BC Q38854056-7015DDB1-394C-430C-AFFE-9A4FC3B38DFF Q38988561-71C5A9B4-F5EC-4DE4-872C-E87915CE176A Q39697040-028EBF39-CE9C-4314-8A18-A385C021D11E Q41481421-ED8FCB2A-A395-4C52-B0B0-C032511DC377 Q44748619-458FA2F3-4122-4AF6-845D-1BB087F8C1CC Q47246640-9C5481B8-10EF-48E8-A632-D60115F5F51F Q47285215-CCD50528-A702-40F8-8552-46C768FB1D03 Q50350640-82C2A72F-A840-413D-881B-14C8AF9E9120 Q53269544-EB8FDFC6-6CAA-4626-968C-EC29F666C0D1 Q53296926-CB2763A8-D908-488F-877C-AB87D0365F21 Q54382634-B6BEDE4F-9DB3-46DF-A7E2-DECEC218717A Q55058738-DCC8E439-AD26-4E18-AD68-4BF87B53A5FA Q55259288-32639844-4449-4BB3-BCAF-AB53AE85FA73 Q57116792-1F9DAEB5-D0FC-4DB1-99E0-79690CC9EC8B Q59125685-860B5E29-7819-475A-8284-FE8175F1B173

P2860

Peritumoral activated hepatic stellate cells predict poor clinical outcome in hepatocellular carcinoma after curative resection.

http://www.wikidata.org/entity/Q46086837

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh-hant

name

Peritumoral activated hepatic ...... noma after curative resection.

@en

Peritumoral activated hepatic ...... noma after curative resection.

@nl

type

label

Peritumoral activated hepatic ...... noma after curative resection.

@en

Peritumoral activated hepatic ...... noma after curative resection.

@nl

prefLabel

Peritumoral activated hepatic ...... noma after curative resection.

@en

Peritumoral activated hepatic ...... noma after curative resection.

@nl

P1433

Q46086837-37073216-0BA0-4C27-84BE-A138C23C35E2

P1476

Q46086837-E70B2EE3-E01A-4A7A-828A-7F1D76167A03

P2093

Q46086837-0BD59916-F502-445B-A93B-62D1D089C5D1

Q46086837-1DA80C39-3D17-4443-9ACD-12E39FBEBF91

Q46086837-3AB03A70-B8F0-474A-A1F3-F0190352BF6E

Q46086837-435C63A5-50C1-4DDC-BC0B-BF7CD73C728B

Q46086837-71A64FBF-51B7-4B6B-979E-88BFC767D40B

Q46086837-8CF95890-18A7-4753-B526-3F0EF1ACAFEE

Q46086837-93E11556-AD4E-464C-AA07-572AFBB6424C

Q46086837-9EBDE6B3-5BAF-4BF7-8F75-009A6931A065

P2860

Q46086837-06106740-9316-4DCA-9EF9-286C3CEA8C82

Q46086837-0F20FAFB-0EA9-42A0-98D1-A7F1918A3254

Q46086837-14144DEC-6C7A-4EC5-A86D-36EA8E5A3810

Q46086837-23CCCA31-B35C-4429-A8B6-974122529B2B

Q46086837-29A94137-64EE-4565-AF3A-76BD10D1AC57

Q46086837-2CFEA176-72FD-48F3-9F3F-1BCD13298670

Q46086837-39591A72-138B-49C0-93A0-F9BDA7D4B4D2

Q46086837-4E62B56D-EE6C-4FDE-B14D-13C11555F055

Q46086837-5AEA7130-F0CE-4525-92F3-E581D48B3D86

Q46086837-71D5FA7A-3B38-4048-8A90-286E756B56A1

P304

Q46086837-0157DDAA-A283-4CBD-8C6C-BABF0A86AA54

P31

Q46086837-8490067B-73F1-4ACA-A38A-95180F499063

P356

Q46086837-BFDCB40D-FBCA-459D-8E92-52B4237C79A8

P407

Q46086837-5889B0B1-60FA-4044-8C50-EEFB39F95910

P433

Q46086837-5E50DC0B-8820-459D-B536-34E798D0452D

P478

Q46086837-ED030B52-82DD-438E-AEB8-9CA38A2073CD

P577

Q46086837-0ACF367F-48A7-4696-904F-53246716EBFD

P5875

Q46086837-04C54137-71F5-4571-A31A-78B6D47239C4

P698

Q46086837-E0DCFF99-8A15-4A0C-A1A8-FFD41FA2B3EE

P356

AJCP86PPBNGOHNNL

P1433

American Journal of Clinical Pathology

P1476

Peritumoral activated hepatic ...... noma after curative resection.

@en

P2093

Jia Fan

http://www.w3.org/2001/XMLSchema#string

Jian Zhou

http://www.w3.org/2001/XMLSchema#string

Min-Jie Ju

http://www.w3.org/2001/XMLSchema#string

Qiang Gao

http://www.w3.org/2001/XMLSchema#string

Shuang-Jian Qiu

http://www.w3.org/2001/XMLSchema#string

Yi-Wei Li

http://www.w3.org/2001/XMLSchema#string

Yong-Sheng Xiao

http://www.w3.org/2001/XMLSchema#string

Zhao-You Tang

http://www.w3.org/2001/XMLSchema#string

P2860

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Global cancer statistics, 2002

Intrahepatic expression of the hepatic stellate cell marker fibroblast activation protein correlates with the degree of fibrosis in hepatitis C virus infection

Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes

Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver

Cultured human liver fat-storing cells produce monocyte chemotactic protein-1. Regulation by proinflammatory cytokines.

ADAM12 in human liver cancers: TGF-beta-regulated expression in stellate cells is associated with matrix remodeling.

Prognosis of hepatocellular carcinoma: comparison of 7 staging systems in an American cohort.

Growth and spread of hepatocellular carcinoma. A review of 240 consecutive autopsy cases.

Proangiogenic cytokines as hypoxia-dependent factors stimulating migration of human hepatic stellate cells

P304

498-510

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1309/AJCP86PPBNGOHNNL

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

131

http://www.w3.org/2001/XMLSchema#string

P577

2009-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24203973

http://www.w3.org/2001/XMLSchema#string

P698

19289585

http://www.w3.org/2001/XMLSchema#string